REG - Alpha Growth PLC - Release of 2021 Annual Report

Alpha GrowthAnnouncement

31/05/2022 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220531:nRSe2821Na&default-theme=true

RNS Number : 2821N  Alpha Growth PLC  31 May 2022

 

The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulation (EU) No.
596/2014 (as in force in the United Kingdom pursuant to the European Union
(Withdrawal) Act 2018). Upon the publication of this announcement, this inside
information is now considered to be in the public domain

 

Alpha Growth Plc

("Alpha", or the "Company")

 

Release of 2021 Annual Report

 

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services
specialist in the growing life insurance linked longevity asset class, is
pleased to announce the release of its Annual Report & Financial
Statements for the sixteen months ended 31 December 2021 (the '2021 Annual
Report'). The sixteen-month period is the result of aligning the year end
reporting of all group companies. The 2021 Annual Report is available at
www.algwplc.com (http://www.algwplc.com) .

 

During this period, the Company made significant investments into its various
strategies, which included the announced acquisition of Providence Life and
Assurance Company, a Bermudan life assurance company with over £225 million
of gross assets. This acquisition, together with continued subscriptions into
the BlackOak Alpha Growth Fund, has led to a significant increase in revenue
to £2,645,172 for the period ending 31 December 2021 vs £81,592 for 2020.
The increased investments, which included acquisition costs and expansion of
Providence's operations, and marketing for the BlackOak Alpha Growth Fund,
resulted in a loss for the sixteen-month period of £1,666,304 vs £567,200
for 2020.

 

Despite the loss, the Company achieved net cash inflow for the sixteen months
to 31 December 2021 of £151,903 vs 2020 outflow of £130,321.  The Group
anticipates to be break even on an operating profits basis by the end of 2022.
The Company does not envisage a fundraise, given the number of outstanding
warrants available, as well as the supportive nature of those holding the
warrants.

 

The Company plans to modestly increase head count at the subsidiary level and
maintain the current level of executives, with the possibility of adding an
additional director. Given the achievements of the past sixteen months, the
Directors were awarded outstanding options in line with the arrangements set
out in the IPO prospectus of the Company. The options are for five years, with
an exercise price of 2.95p.

 

For 2022, we continue with our 2B plan as previously announced - the 2B plan
is Alpha Growth's strategy of achieving $2bn AUM by 2025. This strategy
includes expanding our activities within the life insurance business and
continuing with the growth of BlackOak Alpha Growth Fund. Part of the
expansion includes the previously announced acquisition of a Guernsey
insurance company which is expected to complete in the next quarter, and which
will accrete significant assets under management and is also expected to
contribute to revenue and profits, whilst our head office costs will only
increase marginally.

 

Gobind Sahney, Executive Chairman commented, "This report covers a
transformation period for Alpha Growth and one which has seen tremendous
growth of AUM and its associated revenue, it's also seen us complete on one
significant acquisition within the insurance space and sign a share purchase
agreement for another - with only regulatory approval to be given.

 

We are ahead of schedule with our 2B plan and will update the market when
appropriate, as we progress towards our $2bn AUM target we will once again see
revenue increase significantly. Our annual general meeting is scheduled for
June 20th and I look forward to discussing this report further, and the
progress we're making at Alpha Growth."

 

The 2021 Annual Report will in due course be available for inspection at
(http://www.morningstar.co.uk/uk/NSM)
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

For more information, please visit www.algwplc.com or contact the following:

 

 Alpha Growth Plc                                              +44 (0) 20 3959 8600
 Gobind Sahney, Executive Chairman                             info@algwplc.com (mailto:info@algwplc.com)

 Arden Partners plc                                            +44 (0) 20 7614 5900
 Ruari McGirr / Alexandra Campbell-Harris (Corporate Finance)

 UK Investor Relations - Mark Treharne                         ir@algwplc.com (mailto:ir@algwplc.com)

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist
consultancy, advisory, and supplementary services to institutional and
qualified investors globally in the multi-billion dollar market of life
insurance linked longevity assets. Building on its well-established network,
the Alpha Growth Group has a unique position in the longevity asset services
and investment business, as a listed entity with global reach. The Group's
strategy is to expand its advisory and business services via acquisitions and
joint ventures in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are in need of
specialised skills and unique access to deploy their financial resource in
longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital
and commodity markets.  Its value is a function of time because as time
passes the value gets closer to the face value of the policy. Hence creating a
steady increase in the net asset value of the investment. This makes it highly
attractive to investors wishing to counteract volatility within an investment
portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate
in the USA where the structured and life settlement market is highly
regulated.

 

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking,
which reflect the Company's or, as appropriate, the Company's directors'
current expectations and projections about future events. By their nature,
forward-looking statements involve a number of risks, uncertainties and
assumptions that could cause actual results or events to differ materially
from those expressed or implied by the forward-looking statements. These
risks, uncertainties and assumptions could adversely affect the outcome and
financial effects of the plans and events described herein. Forward-looking
statements contained in this document regarding past trends or activities
should not be taken as a representation that such trends or activities will
continue in the future. The Company does not undertake any obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise. You should not place undue reliance
on forward- looking statements, which speak only as of the date of this
document.  Readers should not treat the contents of this document as advice
relating to legal, taxation or investment matters, and are to make their own
assessments concerning these and other consequences, including the merits of
information and the risks.  Readers of this announcement are advised to
conduct their own due diligence and agree to be bound by the limitations of
this disclaimer.

 

Important Notice

The content of this announcement has not been approved by an authorised person
within the meaning of the Financial Services and Markets Act 2000 (FSMA). This
announcement has been issued by and is the sole responsibility of the Company.
The information in this announcement is subject to change.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSXBLFXLELZBBV